Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restart: FMT in Anorexia Nervosa
NCT07574892Phase 1Not yet recruiting
- Sponsor
- Haukeland University Hospital
- Start
- Dec 2026
- Primary completion
- Dec 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Fecal Microbiota Transplantation Capsule in anorexia nervosa (AN) (2 arms), sponsored by Haukeland University Hospital. Primary endpoint: Feasibility of performing treatment with psychotherapy as usual (TAU) in combination with a single dose of fecal microbiota transplantation at 1 year. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT07574892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07574892.